Avelas Biosciences Secures $550,000 Series B Funding Round

  • Feed Type
  • Date
    9/10/2014
  • Company Name
    Avelas Biosciences
  • Mailing Address
    11099 N. Torrey Pines Road La Jolla, CA 92037 USA
  • Company Description
    At Avelas Biosciences, our mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients.
  • Website
    http://www.avelasbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $550,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The money will help to fund a first-in-man study of its proprietary fluorescent peptide that lights up cancerous cells in real time during breast cancer surgery.
  • M&A Terms
  • Venture Investor

Trending on Xconomy